Description of Research Expertise:
Diabetes and obesity clinical trials.
Thompson C., Abu Dayyeh B., Kushner R., Sullivan S., Schorr A, Amaro A, Apovian C, Fullum T, Zarrinpar A, Jensen M, Stein A, Edmundowicz S, Kahaleh M, Ryou M, Bohning J.M., Ginsberg G., Huang C, Tran D., Martin J., Jaffe D., Farraye F., Ho S., Kumar N., Harakal D., Young M., Thomas C., Shukla A., Ryan M., Haas M., Goldsmith H., McCrea J.: Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial American Journal of Gastroenterology 112 (3): 447-457,2017.
Use of Liraglutide in Childhood Onset Non-Craniopharyngioma Related Hypothalamic Obesity. Poster presentation at the Obesity Society annual meeting, Los Angeles, CA in November 2015. : 2015.
Vetter ML, Amaro A: Nutritional management of type 2 diabetes mellitus and obesity and pharmacologic therapies to facilitate weight loss. Postgrad Med. 2014 Jan;126(1):139-52. : 2014.
Amaro A., Fabbrini E., Kars M., Yue P, Schonfeld G.: Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia Gastroenterology 139 (1): 149-153,2010.
Amaro A., Kars M., Fabbrini E., Mohammed B., Yue P, Schonfeld G.: Increased intrahepatic triglyceride content does not cause insulin resistance in subjects with familial hypobetalipoproteinemia The Obesity Society Annual Scientific Meeting, Washington, DC : 2009.
Baker M., Amaro A., Fabbrini E., Mohammed S.: Measures of insulin resistance in extremely obese subjects before and after gastric bypass surgery. Presented at the 3rd Annual Research Training Symposium and Poster Session, Washington University School of Medicine, St. Louis, MO : 2008.
Severe hypocalcemia after intravenous bisphosphonate infusion in treated vitamin D deficiency Presented at the American College of Physicians Illinois Associates and Chapter Meeting : 2003.